Research location
Austell
Georgia, United States
Advertisement
Research activity in Austell
Georgia, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 128 trials and 130 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Austell
128 linked trials · page 1 of 3Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)NCT07379827 · 2026-02-26 · 1 site observation
RECRUITING
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood PressureNCT06742723 · 2025-03-03 · 1 site observation
RECRUITING
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung CancerNCT05624996 · 2023-07-12 · 1 site observation
RECRUITING
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the BrainNCT06500455 · 2024-12-12 · 1 site observation
ACTIVE_NOT_RECRUITING
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier DetectionNCT05776225 · 2023-08-11 · 1 site observation
COMPLETED
A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial HypertensionNCT05203510 · 2022-10-20 · 1 site observation
ACTIVE_NOT_RECRUITING
Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean StudyNCT05053152 · 2022-04-20 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPCNCT04821622 · 2021-05-12 · 2 site observations
ACTIVE_NOT_RECRUITING
Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C MutationNCT04685135 · 2021-02-23 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary HypertensionNCT03267108 · 2020-12-14 · 1 site observation
TERMINATED
A Dual-center Study Evaluating Clinical Acceptance of a NPWT Wound Care SystemNCT04593693 · 2020-12-10 · 1 site observation
COMPLETED
Imaging Study to Investigate Safety and Diagnostic Performance of 18F rhPSMA 7.3 PET Ligand in Suspected Prostate Cancer RecurrenceNCT04186845 · 2020-05-04 · 1 site observation
COMPLETED
Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer.NCT04186819 · 2020-03-02 · 1 site observation
COMPLETED
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionNCT03683186 · 2019-09-23 · 1 site observation
ENROLLING_BY_INVITATION
EXPEDITE: A Study of Remodulin Induction Followed by Orenitram Optimization to Treat Pulmonary Arterial HypertensionNCT03497689 · 2019-01-31 · 1 site observation
COMPLETED
A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH PatientsNCT03626688 · 2019-01-24 · 1 site observation
COMPLETED
Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)NCT03794583 · 2018-12-21 · 1 site observation
TERMINATED
A Study With BPS-314d-MR-PAH-303 in Participants With Pulmonary Arterial HypertensionNCT03657095 · 2018-12-10 · 1 site observation
TERMINATED
A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD)NCT03496623 · 2018-05-08 · 1 site observation
TERMINATED
Open-label Extension of Oral Treprostinil in Subjects With PH Associated With HFpEFNCT03043651 · 2018-01-30 · 1 site observation
TERMINATED
A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary FibrosisNCT05747508 · 2017-12-29 · 1 site observation
UNKNOWN
Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection FractionNCT03037580 · 2017-08-15 · 1 site observation
TERMINATED
Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United StatesNCT03197688 · 2017-08-03 · 1 site observation
COMPLETED
ADAPT - A Patient Registry of the Real-world Use of Orenitram®NCT03045029 · 2017-07-18 · 1 site observation
ACTIVE_NOT_RECRUITING
Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGERNCT03068130 · 2017-04-18 · 1 site observation
TERMINATED
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFENCT02630316 · 2017-02-03 · 1 site observation
COMPLETED
Palbociclib in Real World PracticeNCT03280303 · 2017-01-04 · 1 site observation
COMPLETED
Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYSTNCT02657356 · 2016-10-04 · 1 site observation
TERMINATED
An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFENCT02633293 · 2016-09-15 · 1 site observation
TERMINATED
Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAHNCT02725372 · 2016-04-01 · 1 site observation
TERMINATED
Study to Assess the Tolerability and the Safety of the Transition From Inhaled Treprostinil to Oral Selexipag in Patients With Pulmonary Arterial HypertensionNCT02471183 · 2015-10-12 · 1 site observation
COMPLETED
PORtopulmonary Hypertension Treatment wIth maCitentan - a randOmized Clinical TrialNCT02382016 · 2015-06-23 · 1 site observation
COMPLETED
A Study to Optimize Care for Lung Cancer Patients Undergoing Video-Assisted Thoracoscopic Surgery (VATS)NCT02502695 · 2015-06-01 · 1 site observation
COMPLETED
Measuring Outcomes In Patients With Pulmonary Arterial Hypertension Not on Active Treatment (MOTION)NCT02191137 · 2014-09-23 · 1 site observation
COMPLETED
A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT02164513 · 2014-06-30 · 1 site observation
COMPLETED
Extension Study to Evaluate the Safety and Efficacy of PT003, PT001, and PT005 in Subjects With Moderate to Very Severe COPD, With Spiriva® Handihaler® (PINNACLE 3)NCT01970878 · 2013-11-01 · 1 site observation
COMPLETED
Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)NCT01942135 · 2013-09-26 · 1 site observation
COMPLETED
An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial HypertensionNCT01560637 · 2013-09-11 · 1 site observation
COMPLETED
Beraprost-314d Added-on to Tyvaso® (BEAT)NCT01908699 · 2013-05-31 · 1 site observation
COMPLETED
Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD); (PINNACLE 1)NCT01854645 · 2013-05-01 · 1 site observation
COMPLETED
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT InstrumentNCT01841762 · 2013-04-01 · 1 site observation
COMPLETED
Trinity™ BIOLOX Delta™ CoC THR Multi-center StudyNCT01921309 · 2012-12-01 · 1 site observation
UNKNOWN
Early Diagnosis of Pulmonary NodulesNCT01752114 · 2012-10-01 · 1 site observation
COMPLETED
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary DiseaseNCT01706536 · 2012-10-01 · 1 site observation
COMPLETED
Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®NCT01694771 · 2012-09-01 · 1 site observation
COMPLETED
Investigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 2NCT01662986 · 2012-08-01 · 1 site observation
COMPLETED
Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral MonotherapyNCT01560624 · 2012-06-26 · 1 site observation
COMPLETED
Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)NCT01601704 · 2012-06-01 · 1 site observation
TERMINATED
Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)NCT01572792 · 2012-04-01 · 1 site observation
COMPLETED
Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients.NCT01533935 · 2012-02-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.